$0.88
1.55% day before yesterday
Nasdaq, Oct 03, 10:00 pm CET

Nautilus Biotechnology Stock price

$0.88
+0.24 38.12% 1M
+0.13 17.52% 6M
-0.80 47.46% YTD
-1.75 66.44% 1Y
-1.27 58.95% 3Y
-9.67 91.63% 5Y
-9.56 91.55% 10Y
-9.56 91.55% 20Y
Nasdaq, Closing price Fri, Oct 03 2025
+0.01 1.55%

Key metrics

Basic
Market capitalization
$111.5m
Enterprise Value
$-27.3m
Net debt
positive
Cash
$138.8m
Shares outstanding
126.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.5
P/B
0.6
Financial Health
Equity Ratio
86.0%
Return on Equity
-33.9%
ROCE
-35.9%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-76.7m | $-69.8m
EBIT
$-78.7m | $-79.4m
Net Income
$-68.7m | $-73.3m
Free Cash Flow
$-58.5m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
2.5% | 12.2%
EBIT
1.2% | 2.6%
Net Income
-1.8% | -3.6%
Free Cash Flow
-1.1%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-0.6
FCF per Share
$-0.5
Short interest
0.4%
Employees
128
Rev per Employee
$0.0
Show more

Is Nautilus Biotechnology a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Nautilus Biotechnology Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Nautilus Biotechnology forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Nautilus Biotechnology forecast:

Buy
88%
Hold
13%

Financial data from Nautilus Biotechnology

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 30 30
3% 3%
-
- Research and Development Expense 47 47
3% 3%
-
-77 -77
3% 3%
-
- Depreciation and Amortization 2 2
100% 100%
-
EBIT (Operating Income) EBIT -79 -79
1% 1%
-
Net Profit -69 -69
2% 2%
-

In millions USD.

Don't miss a Thing! We will send you all news about Nautilus Biotechnology directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nautilus Biotechnology Stock News

Neutral
Seeking Alpha
26 days ago
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 1:50 PM EDT Company Participants Sujal Patel - Co-Founder, CEO, President, Secretary & Director Conference Call Participants Yuko Oku - Morgan Stanley, Research Division Presentation Yuko Oku Equity Analyst Hello. Hi. My name is Yuko Oku, and I work on the Life Science Tools and...
Neutral
GlobeNewsWire
about one month ago
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences.
Neutral
Seeking Alpha
2 months ago
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q2 2025 Earnings Call July 31, 2025 8:30 AM ET Company Participants Anna Mowry - CFO & Treasurer Parag Mallick - Co-Founder, Chief Scientist & Director Sujal M. Patel - Co-Founder, CEO, President, Secretary & Director Conference Call Participants Daniel Gregory Brennan - TD Cowen, Research Division Subhalaxmi T.
More Nautilus Biotechnology News

Company Profile

Nautilus Biotechnology, Inc. develops proteomics platform for analyzing and quantifying the human proteome. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.

Head office United States
CEO Sujal Patel
Employees 128
Founded 2016
Website www.nautilus.bio

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today